Michael Plater, Ph.D. Chief Business Officer
Dr. Plater serves as our Chief Business Officer and is responsible for strategic planning and business development, as well as analytics, competitive intelligence and establishing strategic alliances with partners that best complement our R&D capabilities and pipeline.
Dr. Plater has over 20 years of global pharmaceuticals experience in diverse leadership roles at GlaxoSmithKline and Novartis.
During his tenure at GSK Dr. Plater completed substantial divestment, market access and licensing transactions across Asia-Pacific, Europe and the U.S. and managed U.S. government contracting.
Dr. Plater obtained his Ph.D. in Molecular Genetics and Protein Biochemistry from the Wolfson Laboratory, University Reading, U.K.